See the Glossary for more terms.
Concepts represent early planning stages for program announcements, request for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to the Opportunities and Announcements portal.
NB: Council approval does not guarantee that a concept will become an initiative.
For the published request for applications, see the July 2, 2014, Guide announcement, NIAID SBIR-Technology Transfer Direct Phase II (SBIR-TT) (R44).
For the published broad agency announcement, see the May 2, 2014, solicitation, Advanced Development of Multiplex Diagnostic Platforms for Infectious Diseases.
For the published broad agency announcement, see the June 13, 2014, solicitation, Targeting Therapeutics Development to Relieve Bottlenecks.
Request for Proposals
Contact: Michael Finn
Objective: To provide access to high-quality, standardized strains and reagents to encourage and facilitate research on NIAID pathogens and agents, and ultimately advance the development of medical countermeasures.
Description: This initiative will provide support for a biological resource repository to include reference reagents for current DMID and NIAID high-priority pathogens (e.g., TB, malaria, influenza, antimicrobial resistance, biodefense) and other emerging/reemerging diseases, with flexibility to respond to future priorities. Specific activities include acquiring, authenticating, producing, preserving, storing, and distributing research and reference reagents to support the infectious diseases research community. The proposed repository will serve basic through applied researchers across the NIAID extramural portfolio, as well as investigators around the globe.
Last Updated July 03, 2014
Last Reviewed March 26, 2014